These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38577460)

  • 1. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome.
    Agarwal A; Biswas S; Swaroop S; Aggarwal A; Agarwal A; Jain G; Elhence A; Vaidya A; Gupte A; Mohanka R; Kumar R; Mishra AK; Gamanagatti S; Paul SB; Acharya SK; Shukla A; Shalimar
    World J Gastrointest Oncol; 2024 Mar; 16(3):699-715. PubMed ID: 38577460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
    Sakr M; Abdelhakam SM; Dabbous H; Hamed A; Hefny Z; Abdelmoaty W; Shaker M; El-Gharib M; Eldorry A
    Liver Int; 2017 Mar; 37(3):415-422. PubMed ID: 27507647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
    Liu FY; Wang MQ; Duan F; Fan QS; Song P; Wang Y
    BMC Gastroenterol; 2013 Jun; 13():105. PubMed ID: 23800233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.
    Park H; Yoon JY; Park KH; Kim DY; Ahn SH; Han KH; Chon CY; Park JY
    World J Gastroenterol; 2012 Apr; 18(16):1946-52. PubMed ID: 22563176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.
    Wang YD; Xue HZ; Zhang X; Xu ZQ; Jiang QF; Shen Q; Yu M; Li K; Jia M
    Chin Med J (Engl); 2013; 126(19):3632-8. PubMed ID: 24112155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report.
    Kim CH; Choi GH; Na HY; Yoon CJ; Cho JY; Jang S; Kim JH; Jang ES; Kim JW; Jeong SH
    J Liver Cancer; 2022 Sep; 22(2):194-201. PubMed ID: 37383405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
    Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
    Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review.
    Ren W; Qi X; Yang Z; Han G; Fan D
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):830-41. PubMed ID: 23411869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
    Van Wettere M; Purcell Y; Bruno O; Payancé A; Plessier A; Rautou PE; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
    J Hepatol; 2019 Jun; 70(6):1123-1132. PubMed ID: 30654065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Li WD; Yu HY; Qian AM; Rong JJ; Zhang YQ; Li XQ
    Eur Radiol; 2017 Mar; 27(3):1227-1237. PubMed ID: 27387875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.
    Sonavane AD; Amarapurkar DN; Rathod KR; Punamiya SJ
    J Clin Exp Hepatol; 2019; 9(1):56-61. PubMed ID: 30765940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.
    Dilawari JB; Bambery P; Chawla Y; Kaur U; Bhusnurmath SR; Malhotra HS; Sood GK; Mitra SK; Khanna SK; Walia BS
    Medicine (Baltimore); 1994 Jan; 73(1):21-36. PubMed ID: 8309360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction.
    Paul SB; Shalimar ; Sreenivas V; Gamanagatti SR; Sharma H; Dhamija E; Acharya SK
    Aliment Pharmacol Ther; 2015 May; 41(10):961-71. PubMed ID: 25809735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.
    Li KS; Guo S; Chen YX; Zhang ZL
    Front Oncol; 2022; 12():1075685. PubMed ID: 36568193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion.
    Okuda K; Kage M; Shrestha SM
    Hepatology; 1998 Nov; 28(5):1191-8. PubMed ID: 9794901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon venoplasty as primary modality of treatment in children with Budd-Chiari syndrome.
    Redkar R; Raj V; Tewari S; Sharma R; Joshi S
    J Pediatr Surg; 2020 Oct; 55(10):2183-2186. PubMed ID: 32553452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nationwide Analysis of Budd-Chiari Syndrome in the United States.
    Alukal JJ; Zhang T; Thuluvath PJ
    J Clin Exp Hepatol; 2021; 11(2):181-187. PubMed ID: 33746442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Budd-Chiari syndrome in children and adolescents: therapeutic radiological intervention].
    Wang L; Zu MH; Gu YM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Teng F; Hua QJ
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):590-4. PubMed ID: 24225289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of primary Budd-Chiari syndrome due to Behçet's syndrome.
    Sakr MA; Reda MA; Ebada HE; Abdelmoaty AS; Hefny ZM; Ibrahim ZH; Aboelmaaty ME
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):503-512. PubMed ID: 31735495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.